Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Operating Margin (2019 - 2025)

Historic Operating Margin for aTYR PHARMA (ATYR) over the last 6 years, with Q3 2025 value amounting to 14076.32%.

  • aTYR PHARMA's Operating Margin changed N/A to 14076.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 41395.26%, marking a year-over-year decrease of 124365400.0%. This contributed to the annual value of 28899.57% for FY2024, which is 133417800.0% down from last year.
  • According to the latest figures from Q3 2025, aTYR PHARMA's Operating Margin is 14076.32%.
  • aTYR PHARMA's 5-year Operating Margin high stood at 76.55% for Q4 2022, and its period low was 14076.32% during Q3 2025.
  • For the 4-year period, aTYR PHARMA's Operating Margin averaged around 6201.42%, with its median value being 5326.4% (2024).